Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialLennart Hansson, S. Westerling, Alberto Zanchetti et al.|The Lancet|1998Cited by 5.8k
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialBjörn Dahlöf, Jan Östergren, Gordon T. McInnes et al.|The Lancet|2005Cited by 2.9k
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLars Lindholm, Steven Snapinn, Hans Ibsen et al.|The Lancet|2002Cited by 1.6k
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trialGeorge L. Bakris, Michael A. Weber, Pantelis Sarafidis et al.|The Lancet|2010Cited by 518
Generic and therapeutic substitution: a viewpoint on achieving best practice in EuropeA. E. Johnston, José Luis Zamorano, Roland Asmar et al.|British Journal of Clinical Pharmacology|2011Cited by 49